Morgan Stanley
-
-
-
-
-
-
-
GSK sees sales growth in 2022 after quarterly beat, prepares for spin-off
-
-
-
-
-
-
-
GlaxoSmithKline (GSK) Pfizer (PFE) Joint Venture Details - Morgan Stanley
-
-
-
-
-
-
-
GSK pulls out of $20 billion race for Pfizer consumer assets
-
-
-
-
-
-
-
Morgan Stanley Downgrades GlaxoSmithKline (GSK) to Underweight
-
-
-
-
-
-
-
Morgan Stanley Downgrades GlaxoSmithKline (GSK) to Equalweight
-
-
-
-
-
-
-
StreetInsider.com Pre-Open Movers 5/13: (THRX) (MTSN) (TSLA) Higher; (AFFY) (CEL) (UNXL) Lower (more...)
-
-
-
-
-
-
-
Berkowitz's Fairholme Picks Up Pharma Stakes, and Cisco (CSCO); Swaps General Growth (GGP) for Brookfield (BAM)
-
224,862 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

